
Do you want to understand how #artificialintelligence can support #patient profiling in #precisiononcology. Download your free chapter of Tissue Phenomics here! https://t.co/E8B59IIwQN

Better biomarker signatures change patient lives. #TissuePhenomics: unique tissue signatures that accelerate cancer breakthroughs.

Do you want to understand how #artificialintelligence can support #patient profiling in #precisiononcology. Download your free chapter of Tissue Phenomics here! https://t.co/E8B59IIwQN

Why #AI-powered Biomarker Analysis is the Future of #Cancer Immune Profiling. Checkpoint inhibitors in #immunotherapy are a major medical breakthrough but scientists & doctors must use AI-powered biomarker analysis for better #immuneprofiling. https://t.co/0hLckxwHRj

Researchers characterize lung inflammation associated with some cancer #immunotherapy: Findings might help predict who will react poorly to certain therapies sciencedaily.com/releases/20…

Here's Dr. Andreas Spitzmueller yesterday at #WCLC2019 with his poster: Tumor Proliferation Associated with #Tumor Immunological Status: Study of NSCLC Using Multiplex Immunofluorescence. Thanks to everyone who came by yesterday! wclc2019.iaslc.org/

Do you want to understand how #artificialintelligence can support #patient profiling in #precisiononcology. Download your free chapter of Tissue Phenomics here! https://t.co/A8aq93MXlH

Correct link for the article: jto.org/article/S1556-0864(1…

Please join us at @HISTALIM -Multiplex Histopathology Annual Meeting- in Montpellier Sept.12, 2019. Dr. Florian Leiss & Dr. Ana Hidalgo-Sastre will discuss multiplex digital imaging and patient #immuneprofiling! #immunotherapy https://t.co/GjHRd0reIg


Have you read our latest newsletter yet? Don't miss out - find out about our FREE upcoming events before #SITC19, #ESMO19, and meet us at World CB & CDx! Read it here: https://t.co/ogZWWLhnXj #immunotherapy #immunoOncology #biomarkers


#FridayFacts #immunotherapy #DYK- Did you know: mIHC/IF is the most accurate approach in predicting response to anti-PD-1/PD-L1 therapy? Check out this meta-study to compare here: jamanetwork.com/journals/jam…

During #SITC2019's Workshop on Intratumoral Immunomodulation, the current status of intratumoral immunomodulation will be presented and future directions for the field will be discussed, along with implications for immunotherapy treatments. sitcancer.org/2019/program/p…


The potential and barely tested landscape of combination immunotherapies - birds eye view by Marc Ernstoff, more to come on this from @JaniceM10’s concluding talk on the future of immunotherapy @sitcancer #ACI2019 #CLEedition

#ESMO19 Ian Chau (Session Chair) on what to expect from the Keynote Lecture 'Caloric restriction mimetics, autophagy and #cancer' - 30 September at 12:00 youtu.be/-vx23QQALGE

Congratulations @DendreonNews! Largest Real Word Evidence Suggest 4 year #Survival Benefit in #ProstateCancer With #PROVENGE @ThePCRC @PCFnews @ZEROCancer #CRPC #mCRPC #PCSM #immunotherapy #GUcancer #sipleucel theoncoforum.com/largest-rea…